Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy

by Timothy J. O’Brien, Melvin F. Lorenzo, Yajun Zhao, Robert E. Neal II, John L. Robertson, S. Nahum Goldberg, Rafael V. Davalos
Published 2019-01-01

Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing

by Rebecca M. Brock, Natalie Beitel-White, Natalie Beitel-White, Sheryl Coutermarsh-Ott, Douglas J. Grider, Melvin F. Lorenzo, Veronica M. Ringel-Scaia, Navid Manuchehrabadi, Robert C. G. Martin, Rafael V. Davalos, Irving C. Allen, Irving C. Allen, Irving C. Allen
Published 2020-05-01

High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunityResearch in context

by Veronica M. Ringel-Scaia, Natalie Beitel-White, Melvin F. Lorenzo, Rebecca M. Brock, Kathleen E. Huie, Sheryl Coutermarsh-Ott, Kristin Eden, Dylan K. McDaniel, Scott S. Verbridge, John H. Rossmeisl, Jr, Kenneth J. Oestreich, Rafael V. Davalos, Irving C. Allen
Published 2019-06-01

Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation

by Alissa Hendricks-Wenger, Kenneth N. Aycock, Margaret A. Nagai-Singer, Sheryl Coutermarsh-Ott, Melvin F. Lorenzo, Jessica Gannon, Kyungjun Uh, Kayla Farrell, Natalie Beitel-White, Rebecca M. Brock, Alexander Simon, Holly A. Morrison, Joanne Tuohy, Sherrie Clark-Deener, Eli Vlaisavljevich, Rafael V. Davalos, Kiho Lee, Irving C. Allen
Published 2021-04-01